Humira(CF) pen 40 MG/0.4 MLS
Ended Awarded
- Contract number
- SPE2DB25FKKZX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,423
Award facts
- Contract value 100% obligated
- $24,423.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a widely used biologic medication for treating autoimmune conditions. This firm fixed-price delivery order has a ceiling value of $24,423.01 and is scheduled for ultimate completion by June 3, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The contract was awarded without set-aside status through competitive procurement, reflecting open competition among qualified vendors. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which provides comprehensive pharmaceutical and medical supply support globally for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania, regularly fulfills federal medical procurement needs through its extensive federal contract portfolio with the Defense Logistics Agency and related entities including the Defense Health Agency and U.S. Coast Guard. The contractor maintains significant capability in delivering a broad spectrum of pharmaceutical products, medical devices, vaccines, and specialized healthcare commodities across multiple therapeutic domains, consistently performing under competitively awarded delivery orders with firm fixed pricing. This particular award demonstrates the contractor's role as a critical vendor supporting military and federal healthcare systems' ongoing pharmaceutical supply requirements.
Quick answers
Who was awarded contract SPE2DB25FKKZX?
SPE2DB25FKKZX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 2, 2025.
How much is contract SPE2DB25FKKZX worth?
The government has obligated $24,423 on SPE2DB25FKKZX.
Is contract SPE2DB25FKKZX an order under another contract?
Yes. SPE2DB25FKKZX is a delivery order under SPE2DB24D2101, an indefinite delivery contract.
Was contract SPE2DB25FKKZX competed?
The extent of competition for SPE2DB25FKKZX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award